Piermont Capital Management’s Medifast MED Stock Holding History

Piermont Capital Management’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-2,980	Closed	-$477K	–	174
2018 Q2	$477K	Sell	2,980 -2,800	-48%	-$358K	0.15%	156
2018 Q1	$540K	Buy	+5,780	New	+$432K	0.18%	152
2015 Q2	–	Sell	-18,970	Closed	-$569K	–	240
2015 Q1	$569K	Buy	18,970 +6,400	+51%	+$203K	0.17%	145
2014 Q4	$422K	Hold	12,570	–	–	0.15%	115
2014 Q3	$413K	Buy	+12,570	New	+$386K	0.16%	111

Other funds holding MED

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return

Arrowstreet Capital

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bank of New York Mellon

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Principal Financial Group

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return